# Short-Term Application of Tocilizumab Following Myocardial Infarction

> **NCT02419937** · NA · COMPLETED · sponsor: **Keesler Air Force Base Medical Center** · enrollment: 28 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Tocilizumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02419937
- **Lead sponsor:** Keesler Air Force Base Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02419937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02419937, "Short-Term Application of Tocilizumab Following Myocardial Infarction". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02419937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*